GLYXAMBI FDA approval date

The FDA approved GLYXAMBI on 30 Jan 2015.

FDA approval date
30 Jan 2015

Drug identity has not yet been verified against registry records

Also recorded as EMPAGLIFLOZIN; LINAGLIPTIN

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2015-01-30DayGLYXAMBIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206073", "applicant_as_listed_by_fda": "BOEHRINGER INGELHEIM", "brand_names": ["GLYXAMBI"], "active_ingredients": ["EMPAGLIFLOZIN", "LINAGLIPTIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150130", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026